Communiqués Certara, Inc.

Actions

CERT

US15687V1098

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 06/06/2024			Varia. 5j.	Varia. 1 janv.
17,19 ^USD	-0,87 %		+1,72 %	-2,27 %

05/06	Transcript : Certara, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 11:30 AM
21/05	Certara, Inc. nomme Rona Anhalt au poste de directrice des ressources humaines et Daniel Corcoran au poste de conseiller général	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Certara to Participate in the Jefferies Global Healthcare Conference	29/05	GL
Certara Appoints New Chief Human Resources Officer & General Counsel	21/05	GL
Certara Reports First Quarter 2024 Financial Results	07/05	GL
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform	16/04	GL
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference	09/04	GL
Certara Reports Fourth Quarter 2023 Financial Results	29/02	GL
Certara Reports Fourth Quarter 2023 Financial Results	29/02	AQ
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference	01/02	GL
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies	13/12	GL
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development	21/11	GL
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development	21/11	AQ
Certara Reports Third Quarter 2023 Financial Results	08/11	GL
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference	11/10/23	GL
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software	19/09/23	GL
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software	19/09/23	AQ
Certara to Participate in Upcoming Investor Conferences	29/08/23	GL
Certara Simcyp™ Group Awarded Two New Grants from US FDA	29/08/23	GL
Certara Simcyp™ Group Awarded Two New Grants from US FDA	29/08/23	AQ
Certara Reports Second Quarter 2023 Financial Results	09/08/23	GL
Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset	04/08/23	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Certara, Inc.

Actions

CERT

US15687V1098

Communiqués

Filtres